BOM: Empowering Innovation and Driving Global Impact from the Heart of Brabant
BOM (Brabantse Ontwikkelings Maatschappij) is reshaping the Dutch innovation landscape from within. Based in the Netherlands, BOM has grown into one of Europe’s most active regional development agencies, playing a pivotal role as a public investor in high-impact, deeptech, and climate-focused startups.
Notable performances:
- Participated in 100+ investment rounds since 2020, focusing on the energy transition, circular economy, and high-tech systems.
- Early investor in Acerta Pharma, acquired by AstraZeneca and now valued as a unicorn.
- Backing future unicorns such as Protix(insect-based proteins), Citryll(autoimmune therapeutics) and Sendcloud (e-commerce logistics).
- Actively supports sustainable mobility innovation through initiatives like BOM Green Mobility, including hydrogen and electrification projects.
- Frequently co-invests with leading European VCs, helping to position Brabant as a globally competitive startup hub.
BOM’s distinct strength lies in its dual mission: strengthening regional economic resilience while scaling companies solving systemic global challenges. This makes it a benchmark in the evolving landscape of mission-driven capital deployment.
Sources:
